Published

Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychoactives
Date: 2026-04-13
Source: Crossref
DOI: 10.3390/psychoactives5020012
PubMed: Unavailable

Authors

Penberthy J. Kim A. Wise Fatma Cherup Nicholas Penberthy J. Morgan Mitchell Evaline Burns Madeline Akinlade Oluwafunmilayo Chung David Parmar Harshit Singer Jonathan

Watch author

Derived topics and classifications

psilocybin Brain Imaging Randomized Controlled Trial Safety Randomized Controlled Trial

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1371/journal.pmed.1000121 10.1002/da.20780 10.1016/j.jad.2017.01.030 10.1016/s0140-6736(17)30189-7 10.1056/nejmcp2308707 10.1001/jamapsychiatry.2016.0892 10.1001/jama.293.21.2601 10.1037/0022-006x.75.2.277 10.1016/j.jad.2025.03.173 10.1177/0269881116675513 10.1056/nejmoa2032994 10.1093/ijnp/pyab026

Indexed papers citing this DOI

Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol2026-04-13

Related papers

No close related records were found yet.